|
|||||
|
|

Household products company Kimberly-Clark (NYSE:KMB) met Wall Streets revenue expectations in Q4 CY2025, but sales were flat year on year at $4.08 billion. Its non-GAAP profit of $1.86 per share was 2.7% above analysts’ consensus estimates.
Is now the time to buy KMB? Find out in our full research report (it’s free for active Edge members).
Kimberly-Clark’s fourth quarter results reflected a steady performance in a challenging consumer environment, with revenue in line with Wall Street expectations and a modest non-GAAP earnings beat. Management highlighted that volume and mix gains were achieved despite subdued category growth, citing targeted product innovation and value-focused offerings across price tiers as primary drivers. CEO Michael Hsu noted, “We continue to see ample opportunity to elevate and expand our categories globally.” The company’s focus on expanding its premium product portfolio and executing disciplined cost management supported operating margin improvements.
Looking ahead, Kimberly-Clark’s management expects ongoing consumer sensitivity to value, but believes a robust innovation pipeline and investments in brand strength will drive growth. The integration of Kenview is anticipated to accelerate the company’s shift toward higher-growth, higher-margin categories. CFO Nelson Urdaneta pointed out that productivity initiatives and stable input costs are expected to support further margin expansion, stating, “We expect to expand margins both gross and operating profit margins in the year.” Management cautions that competitive pressures and shifting channel dynamics, particularly in North America, will require continued discipline and agility.
Management attributed quarterly stability to resilient volume growth, disciplined pricing strategies, and the early impacts of innovation and productivity initiatives.
Kimberly-Clark’s outlook is shaped by innovation-led growth, rising productivity, and the integration of Kenview, with cost stability and market dynamics as key factors.
In the coming quarters, our analysts will be monitoring (1) the pace and commercial success of new product launches across personal care and international markets, (2) the degree to which margin improvement is sustained through ongoing productivity gains and stable costs, and (3) the integration milestones and strategic impact of the Kenview acquisition. Shifts in consumer value perception and competitive activity in club and discount channels will also be important indicators of execution.
Kimberly-Clark currently trades at $100.69, in line with $101 just before the earnings. In the wake of this quarter, is it a buy or sell? Find out in our full research report (it’s free).
Your portfolio can’t afford to be based on yesterday’s story. The risk in a handful of heavily crowded stocks is rising daily.
The names generating the next wave of massive growth are right here in our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.
| Feb-13 | |
| Feb-12 | |
| Feb-12 | |
| Feb-12 | |
| Feb-12 | |
| Feb-12 | |
| Feb-12 | |
| Feb-12 | |
| Feb-12 | |
| Feb-11 | |
| Feb-10 | |
| Feb-10 | |
| Feb-09 | |
| Feb-09 | |
| Feb-06 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite